Rahmanian Parwis B, Adams David H, Castillo Javier G, Vassalotti Joseph, Filsoufi Farzan
Department of Cardiothoracic Surgery, Mount Sinai School of Medicine, New York, NY 10029, USA.
J Thorac Cardiovasc Surg. 2008 Apr;135(4):915-22. doi: 10.1016/j.jtcvs.2007.09.027.
Previous studies on outcome of cardiac surgery and its predictors in patients with preoperative kidney failure requiring dialysis have included small numbers of patients with limited follow-up. In addition, predictors of long-term outcome are not well characterized.
This is a retrospective analysis of prospectively collected data for 6694 patients, including 245 (3.7%) patients with end-stage kidney failure requiring dialysis who underwent cardiac surgery between January 1998 and September 2006. Potential predictors of hospital mortality, complications, and late survival were retrospectively analyzed by using multivariate regression models.
Patients with end-stage kidney failure requiring dialysis had a 3.9-times higher hospital mortality rate compared with other cardiac surgery patients (12.7% vs 3.6%, P < .001). Patients with end-stage kidney failure requiring dialysis were younger but presented with more comorbidities and more severe cardiac disease than the control group. After adjusting for potential confounding factors, end-stage kidney failure requiring dialysis was identified as a predictor of hospital mortality (odds ratio, 3.1; P < .001). Patients with end-stage kidney failure requiring dialysis also had an increased risk of postoperative sepsis (odds ratio, 2.7; P < .001) and respiratory failure (odds ratio, 2.0; P < .001). Peripheral vascular disease was an independent predictor of hospital mortality in patients with end-stage kidney failure requiring dialysis (odds ratio, 2.5; P = .001). Long-term survival was significantly decreased in patients with end-stage kidney failure requiring dialysis compared with that seen in the control group (1-year and 5-year survival: 72.3% +/- 3.3% and 39.0% +/- 4.5% vs 94.2% +/- 0.3% and 83.2% +/- 0.6%, P < .001). Peripheral vascular disease (odds ratio, 2.69; P = .008) and previous stroke (odds ratio, 4.37; P < .001) were independent risk factors of late mortality in the subgroup of patients with end-stage kidney failure requiring dialysis.
Preoperative renal failure requiring dialysis is associated with a significant increase in hospital mortality, postoperative sepsis, and respiratory failure in patients undergoing cardiac surgery. In these patients long-term survival is particularly reduced in the presence of advanced atherosclerotic disease.
既往关于术前需要透析的肾衰竭患者心脏手术结局及其预测因素的研究纳入的患者数量较少,随访时间有限。此外,长期结局的预测因素也未得到充分描述。
这是一项对前瞻性收集的6694例患者数据的回顾性分析,其中包括1998年1月至2006年9月期间接受心脏手术的245例(3.7%)终末期肾衰竭需要透析的患者。使用多变量回归模型对医院死亡率、并发症和晚期生存的潜在预测因素进行回顾性分析。
与其他心脏手术患者相比,终末期肾衰竭需要透析的患者医院死亡率高出3.9倍(12.7%对3.6%,P<.001)。终末期肾衰竭需要透析的患者更年轻,但与对照组相比,合并症更多,心脏病更严重。在调整潜在混杂因素后,终末期肾衰竭需要透析被确定为医院死亡率的预测因素(比值比,3.1;P<.001)。终末期肾衰竭需要透析的患者术后发生败血症(比值比,2.7;P<.001)和呼吸衰竭(比值比,2.0;P<.001)的风险也增加。外周血管疾病是终末期肾衰竭需要透析患者医院死亡率的独立预测因素(比值比,2.5;P=.001)。与对照组相比,终末期肾衰竭需要透析的患者长期生存率显著降低(1年和5年生存率:72.3%±3.3%和39.0%±4.5%对94.2%±0.3%和83.2%±0.6%,P<.001)。外周血管疾病(比值比,2.69;P=.008)和既往中风(比值比,4.37;P<.001)是终末期肾衰竭需要透析患者亚组晚期死亡的独立危险因素。
术前需要透析的肾衰竭与心脏手术患者的医院死亡率、术后败血症和呼吸衰竭显著增加相关。在这些患者中,存在晚期动脉粥样硬化疾病时长期生存率尤其降低。